Robert A. Gabbay, MD, PhD, chief medical officer and senior vice president of Joslin Diabetes Center, highlights why stakeholders should attend the Patient-Centered Diabetes Care: Putting Theory into Practice event on April 10-11, in Princeton, NJ.
Robert A. Gabbay, MD, PhD, chief medical officer and senior vice president of Joslin Diabetes Center, highlights why stakeholders should attend the “Patient-Centered Diabetes Care: Putting Theory into Practice” event on April 10-11, in Princeton, NJ. The event, hosted by The American Journal of Managed Care, will cultivate important discussions about diabetes care.
“[It] will bring leaders from all areas of the diabetes epidemic that will focus on innovative new treatments and diagnosis of complications and prevention of complications,” says Dr Gabbay. “We view that these individuals will collectively help to come up with new approaches and ideas that can be applicable to providers, provider organizations, payer organizations, and employers, to really tackle this incredible epidemic that we face.”
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More